Ebpay生命医药出版社

Ebpay生命

102494

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

分阶段认知行为干预对接受化疗的肺癌患者焦虑和抑郁情绪的缓解作用:一项回顾性队列分析

 

Authors Chen L, Sun Y, Yu H, Sun M

Received 3 January 2025

Accepted for publication 26 May 2025

Published 3 June 2025 Volume 2025:18 Pages 3165—3177

DOI http://doi.org/10.2147/JMDH.S506310

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Lei Chen,1 Yongxia Sun,2 Huanhuan Yu,2 Min Sun2 

1Nursing department, Fuyang Tumor Hospital, Fuyang, Anhui, 236000, People’s Republic of China; 2Oncology Department, Fuyang Tumor Hospital, Fuyang, Anhui, 236000, People’s Republic of China

Correspondence: Min Sun, Email sun18055836138@hotmail.com

Background: The success rate of Staged cognitive behavioral intervention (CBI) in reducing emotional discomfort and enhancing the life-quality of patients undergoing chemotherapy for lung cancer was assessed retrospectively in this study.
Objective: The records of 55 affected role received/receiving chemotherapy for lung cancer were examined for Staged CBI.
Methods: In this study, patients’ life related information’s were obtained through demographic questionnaires. The 36-Item Short Form Survey (SF-36) was included as a single question that indicates subjective shifts in well-being. The Functional Assessment of Cancer Therapy-General (FACT-G) and the Lung Cancer Symptom Scale (LCSS) were designed as measuring scales for quality of life (QoL). Cohen’s d indexes were measured to analyze the group’s effectual size. The follow-up data were collected 6– 8 weeks after the Staged CBI sessions.
Results: The SF-36 showed that effect size was large for most of the domains (Cohen’s d > 1.2) and post CBI intervention was not significant except physical function. The FACT-G survey revealed that improvements were significant for observation group vs control for physical well-being (p = 0.004), social well-being (p = 0.007), emotional well-being (p = 0.008), and functional well-being (p = 0.045). The LCSS survey showed clinically marked changes for activity level, daily routine and social activities from 43.86 ± 20.16 to 71.29 ± 25.42, 45.36 ± 32.65 to 72.36 ± 26.78, and 35.36 ± 31.07 to 77.77 ± 28.58, respectively (P > 0.001). The resulting outcomes were significant in getting better the overall Global QoL of the patients. Besides these, the symptoms burden was also promisingly reduced.
Conclusion: The function of CBI in lung cancer chemotherapy patients has not yet been examined retrospectively. This study investigated how CBI affects the treatment of mental health issues and enhances patients’ treatment compliance and quality of life.

Keywords: lung cancer, staged CBI, chemotherapy, retrospective analysis

Download Article[PDF]